Read this extract where Artiman Ventures reviews the big data in drug discovery. Ajit Singh, CEO of Biomalgene, accomplice of Artiman Ventures tries to comprehend this activity with other board members from regarded social insurance organizations. To know more, go to www.artiman.com

1. Artiman Ventures: Big Data in drug Discovery
Artiman ventures and the team reviews the big data in drug discovery. Ajit Singh, previous
CEO of Biolmagene, accomplice of Artiman Ventures tries to comprehend this activity with
other board parts from regarded social insurance organizations.
From Google tracking flu outbreaks via search behavior to companies seeking to reposition
drugs based on in silico analysis, samples flourish of medicinal services being influenced by
Big Data.
At the same time dissimilar to most markets effectively handled by Big Data, life sciences
markets are heavily regulated and traditional methods are deeply entrenched. Still, Big Data
is making advances.
We talk about the effect of information dissection on pill disclosure, VC venture and
medicinal services